Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
102
3.090
 Why?
Ophthalmologic Surgical Procedures
5
2017
58
2.270
 Why?
Angiogenesis Inhibitors
11
2022
216
2.070
 Why?
Retina
11
2016
269
1.790
 Why?
Glaucoma
4
2017
204
1.680
 Why?
Alloys
4
2013
31
1.660
 Why?
Eye Foreign Bodies
5
2016
23
1.650
 Why?
Macular Edema
4
2022
35
1.610
 Why?
Retinal Detachment
6
2019
53
1.580
 Why?
Vitrectomy
7
2019
57
1.530
 Why?
Diabetic Retinopathy
6
2019
149
1.520
 Why?
Glaucoma Drainage Implants
3
2016
47
1.450
 Why?
Retinal Diseases
5
2017
77
1.300
 Why?
Intraocular Pressure
7
2017
277
1.290
 Why?
Nanopores
2
2020
4
1.250
 Why?
Intravitreal Injections
7
2022
46
1.230
 Why?
Membranes, Artificial
2
2020
67
1.220
 Why?
Nanotechnology
2
2020
115
1.140
 Why?
Suction
3
2015
31
1.060
 Why?
Sutures
3
2015
60
1.000
 Why?
Choroidal Neovascularization
4
2011
44
1.000
 Why?
Anterior Eye Segment
2
2017
9
0.990
 Why?
Swine
10
2017
706
0.970
 Why?
Suture Techniques
3
2015
130
0.950
 Why?
Equipment Design
6
2017
516
0.930
 Why?
Lens Implantation, Intraocular
2
2015
57
0.910
 Why?
Retinitis
1
2022
17
0.840
 Why?
Retinal Vasculitis
1
2022
7
0.840
 Why?
Aneurysm
1
2022
29
0.820
 Why?
Antibodies, Monoclonal
6
2020
1262
0.780
 Why?
Vitreoretinopathy, Proliferative
2
2019
10
0.770
 Why?
Vascular Endothelial Growth Factor A
6
2020
504
0.750
 Why?
Immunosuppressive Agents
3
2013
666
0.730
 Why?
Retinal Vessels
2
2015
51
0.730
 Why?
Durapatite
1
2020
32
0.730
 Why?
Disease Models, Animal
8
2020
3582
0.720
 Why?
Cytomegalovirus Retinitis
2
2013
17
0.710
 Why?
Complement System Proteins
2
2020
288
0.700
 Why?
Isoxazoles
2
2013
56
0.700
 Why?
Eye Injuries, Penetrating
3
2016
17
0.700
 Why?
Endophthalmitis
2
2017
25
0.700
 Why?
Scleral Buckling
3
2012
18
0.690
 Why?
Stents
2
2013
477
0.660
 Why?
Fluorocarbons
2
2012
96
0.610
 Why?
Anterior Chamber
1
2017
20
0.580
 Why?
Transducers
1
2017
25
0.580
 Why?
Glucocorticoids
2
2020
551
0.580
 Why?
Strabismus
1
2017
26
0.570
 Why?
Sclera
2
2015
35
0.550
 Why?
Filtering Surgery
1
2016
22
0.550
 Why?
Trabeculectomy
1
2017
65
0.540
 Why?
Surgical Instruments
2
2013
48
0.540
 Why?
Fovea Centralis
2
2006
8
0.530
 Why?
Retinal Perforations
2
2005
12
0.520
 Why?
Laser Therapy
1
2017
99
0.520
 Why?
Ocular Hypertension
1
2016
61
0.520
 Why?
Drug Resistance, Multiple, Viral
2
2013
11
0.520
 Why?
Ophthalmology
2
2013
77
0.510
 Why?
Lenses, Intraocular
1
2015
42
0.500
 Why?
Monitoring, Physiologic
1
2017
252
0.500
 Why?
Tomography, Optical Coherence
7
2015
128
0.500
 Why?
Lasers
1
2015
123
0.500
 Why?
Device Removal
1
2016
128
0.490
 Why?
Prostheses and Implants
1
2016
141
0.480
 Why?
Antiviral Agents
2
2013
648
0.480
 Why?
Ischemia
2
2017
363
0.470
 Why?
Fluorescein Angiography
9
2012
102
0.470
 Why?
Animals
18
2020
32123
0.460
 Why?
Rabbits
3
2020
755
0.450
 Why?
Models, Cardiovascular
1
2015
172
0.450
 Why?
Retinal Degeneration
2
2015
30
0.450
 Why?
Artificial Lens Implant Migration
1
2013
3
0.440
 Why?
Choroid
3
2015
47
0.440
 Why?
Macular Degeneration
6
2015
152
0.430
 Why?
Viscosupplements
1
2012
10
0.430
 Why?
Gravitation
1
2012
20
0.430
 Why?
Silicone Oils
1
2012
26
0.420
 Why?
Silicon
1
2012
14
0.420
 Why?
Pupil Disorders
1
2012
5
0.420
 Why?
Viremia
1
2013
120
0.420
 Why?
Eye Enucleation
1
2012
12
0.420
 Why?
Iris
1
2012
19
0.420
 Why?
Quantum Dots
1
2012
34
0.410
 Why?
Silicone Elastomers
1
2012
7
0.410
 Why?
Prosthesis Implantation
1
2013
139
0.410
 Why?
Uveitis, Posterior
1
2012
12
0.410
 Why?
Surgical Stapling
1
2012
9
0.410
 Why?
Fluocinolone Acetonide
1
2012
16
0.400
 Why?
Electric Stimulation Therapy
1
2012
56
0.400
 Why?
Vitreous Hemorrhage
2
2015
6
0.400
 Why?
Cataract Extraction
1
2013
76
0.390
 Why?
Models, Biological
4
2015
1647
0.390
 Why?
Vascular Endothelial Growth Factors
1
2011
61
0.380
 Why?
Oxygen
1
2015
839
0.360
 Why?
Humans
47
2022
115908
0.360
 Why?
Cytomegalovirus
2
2013
145
0.350
 Why?
Materials Testing
1
2012
357
0.350
 Why?
Anti-Inflammatory Agents
1
2012
447
0.320
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
254
0.310
 Why?
Biocompatible Materials
1
2012
379
0.300
 Why?
Electroretinography
5
2016
40
0.300
 Why?
von Hippel-Lindau Disease
1
2007
12
0.290
 Why?
Antibodies, Monoclonal, Humanized
6
2015
665
0.280
 Why?
Injections
5
2012
163
0.280
 Why?
Pigment Epithelium of Eye
2
2006
34
0.280
 Why?
Drug Implants
2
2020
71
0.280
 Why?
Puerperal Disorders
1
2007
31
0.280
 Why?
Recombinant Fusion Proteins
4
2022
616
0.280
 Why?
Uveal Diseases
1
2006
5
0.270
 Why?
Ocular Hypotension
1
2006
10
0.270
 Why?
Fusobacterium Infections
1
2006
6
0.270
 Why?
Dementia
2
2022
185
0.270
 Why?
Pharyngeal Diseases
1
2006
12
0.270
 Why?
Visual Acuity
7
2019
273
0.270
 Why?
Epiretinal Membrane
1
2005
6
0.270
 Why?
Needles
2
2017
52
0.270
 Why?
Ciliary Body
1
2006
33
0.270
 Why?
Female
26
2022
60086
0.270
 Why?
Telangiectasis
1
2005
6
0.260
 Why?
Rats, Inbred BN
3
2011
53
0.260
 Why?
Uveitis
1
2006
115
0.250
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
104
0.250
 Why?
Kidney Transplantation
2
2013
560
0.250
 Why?
Middle Aged
17
2019
27084
0.240
 Why?
Injections, Intraocular
2
2015
10
0.240
 Why?
Polypropylenes
2
2015
17
0.230
 Why?
Autoimmune Diseases
1
2006
396
0.220
 Why?
Laser Coagulation
3
2012
54
0.210
 Why?
Bevacizumab
6
2015
118
0.210
 Why?
Optic Atrophy
1
2022
10
0.210
 Why?
Hearing Loss, Central
1
2022
5
0.210
 Why?
Rats
4
2012
5035
0.200
 Why?
Retinal Vein Occlusion
2
2015
13
0.200
 Why?
Cell Count
2
2012
304
0.190
 Why?
Dialysis
1
2020
24
0.180
 Why?
Male
21
2019
56128
0.180
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
10
0.180
 Why?
Adult
11
2022
30820
0.180
 Why?
Orbital Neoplasms
1
2000
21
0.180
 Why?
Time Factors
4
2017
6186
0.180
 Why?
Follow-Up Studies
5
2015
4446
0.180
 Why?
Adsorption
1
2020
127
0.180
 Why?
Biomarkers
2
2020
3474
0.170
 Why?
Wet Macular Degeneration
1
2019
32
0.160
 Why?
Geographic Atrophy
1
2019
49
0.160
 Why?
Fluorescein-5-isothiocyanate
2
2009
37
0.160
 Why?
Eye Diseases, Hereditary
1
2018
12
0.160
 Why?
Miniaturization
2
2015
24
0.150
 Why?
Dextrans
2
2009
74
0.150
 Why?
Hypertension
1
2006
1063
0.150
 Why?
Iris Diseases
1
2017
5
0.150
 Why?
Choroid Diseases
1
2017
9
0.150
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
794
0.150
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
13
0.150
 Why?
Dark Adaptation
2
2012
13
0.140
 Why?
Aged, 80 and over
6
2019
6438
0.140
 Why?
Antimony
1
2016
5
0.140
 Why?
Infliximab
2
2007
94
0.140
 Why?
Dose-Response Relationship, Drug
3
2014
1868
0.140
 Why?
Aged
10
2020
19299
0.140
 Why?
Pressure
1
2017
218
0.140
 Why?
Treatment Outcome
9
2016
9166
0.140
 Why?
Polymers
1
2020
464
0.140
 Why?
Sclerostomy
1
2015
4
0.130
 Why?
Foreign-Body Migration
1
2016
39
0.130
 Why?
Gyrate Atrophy
1
2015
2
0.130
 Why?
Vitreoretinal Surgery
1
2015
3
0.130
 Why?
Down Syndrome
1
2000
336
0.130
 Why?
Stress, Mechanical
1
2017
440
0.130
 Why?
Eye Infections, Bacterial
1
2015
26
0.130
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1193
0.130
 Why?
Vitreous Detachment
1
2015
5
0.130
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
36
0.130
 Why?
Partial Pressure
1
2015
28
0.130
 Why?
Equipment Failure Analysis
1
2015
135
0.120
 Why?
Hemoglobin SC Disease
1
2015
15
0.120
 Why?
Biopsy, Needle
1
2015
183
0.120
 Why?
Feedback
1
2015
149
0.120
 Why?
Prosthesis Failure
1
2016
116
0.120
 Why?
Protein Binding
1
2020
1919
0.120
 Why?
Oculomotor Muscles
1
2014
40
0.120
 Why?
International Normalized Ratio
1
2014
45
0.120
 Why?
Postoperative Care
1
2015
222
0.120
 Why?
Diabetes Mellitus, Type 2
2
2012
2091
0.120
 Why?
Exchange Transfusion, Whole Blood
1
2013
15
0.110
 Why?
Retinal Artery Occlusion
1
2013
8
0.110
 Why?
In Vitro Techniques
1
2015
1044
0.110
 Why?
Warfarin
1
2014
136
0.110
 Why?
Tendons
1
2014
120
0.110
 Why?
Metabolomics
1
2018
536
0.110
 Why?
Specific Gravity
1
2012
11
0.110
 Why?
Research Design
1
2019
947
0.110
 Why?
Erythrocyte Transfusion
1
2015
187
0.110
 Why?
Transducers, Pressure
1
2012
15
0.110
 Why?
Antineoplastic Agents
2
2020
1891
0.110
 Why?
Adaptation, Ocular
1
2012
4
0.110
 Why?
Minerals
1
2012
37
0.110
 Why?
Rats, Mutant Strains
1
2012
25
0.110
 Why?
Viscosity
1
2012
82
0.110
 Why?
Pupil
1
2012
13
0.110
 Why?
Adolescent
4
2019
17955
0.100
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.100
 Why?
Acetates
1
2012
95
0.100
 Why?
Retinal Neovascularization
1
2012
20
0.100
 Why?
Endothelium, Corneal
1
2012
15
0.100
 Why?
Sodium Chloride
1
2012
137
0.100
 Why?
Drug Combinations
1
2012
288
0.100
 Why?
Swine, Miniature
1
2012
71
0.100
 Why?
Electrodes, Implanted
1
2012
93
0.100
 Why?
Microsurgery
1
2012
61
0.100
 Why?
Tumor Necrosis Factor-alpha
2
2007
1138
0.100
 Why?
Retinal Ganglion Cells
1
2012
92
0.100
 Why?
Bruch Membrane
1
2011
6
0.100
 Why?
Gold
1
2012
105
0.100
 Why?
Registries
1
2019
1773
0.100
 Why?
Polyglycolic Acid
1
2011
43
0.100
 Why?
Administration, Oral
1
2013
731
0.090
 Why?
Drug Compounding
1
2011
89
0.090
 Why?
Atrial Fibrillation
1
2014
314
0.090
 Why?
Retrospective Studies
8
2015
12616
0.090
 Why?
Dissection
1
2011
52
0.090
 Why?
Computer Simulation
1
2015
887
0.090
 Why?
Delayed-Action Preparations
1
2011
158
0.090
 Why?
Anemia, Sickle Cell
1
2013
221
0.090
 Why?
Models, Animal
1
2012
350
0.090
 Why?
Lactic Acid
1
2011
276
0.080
 Why?
Bacteria
1
2015
731
0.080
 Why?
Cell Survival
1
2012
1026
0.080
 Why?
Scotoma
1
2008
4
0.080
 Why?
Proliferating Cell Nuclear Antigen
1
2007
49
0.070
 Why?
Severity of Illness Index
2
2014
2598
0.070
 Why?
Pilot Projects
1
2012
1374
0.070
 Why?
Optic Neuropathy, Ischemic
1
2007
30
0.070
 Why?
Papilledema
1
2007
38
0.070
 Why?
Visual Fields
3
2007
77
0.070
 Why?
Young Adult
2
2019
10518
0.070
 Why?
RNA, Catalytic
1
2007
182
0.070
 Why?
Retinitis Pigmentosa
1
2006
16
0.070
 Why?
Glycogen Storage Disease Type IIb
1
2006
22
0.070
 Why?
Triamcinolone Acetonide
1
2006
27
0.070
 Why?
Fusobacterium necrophorum
1
2006
1
0.070
 Why?
Polyethylene Glycols
1
2011
576
0.070
 Why?
Indocyanine Green
1
2005
13
0.070
 Why?
Vision, Low
3
2013
14
0.070
 Why?
Myopia
1
2006
37
0.070
 Why?
Coloring Agents
1
2005
71
0.070
 Why?
Eye Injuries
1
2006
45
0.060
 Why?
Infusions, Intravenous
1
2006
374
0.060
 Why?
Staining and Labeling
1
2005
139
0.060
 Why?
Syndrome
1
2006
339
0.060
 Why?
Cataract
1
2006
185
0.060
 Why?
Multivariate Analysis
2
2019
1444
0.050
 Why?
Diagnosis, Differential
1
2007
1359
0.050
 Why?
Ranibizumab
2
2013
18
0.050
 Why?
Blindness
2
2013
37
0.050
 Why?
Postoperative Complications
1
2012
2167
0.050
 Why?
Keratitis
1
2000
11
0.050
 Why?
Exophthalmos
1
2000
19
0.050
 Why?
Chronic Disease
1
2006
1602
0.040
 Why?
Immunophenotyping
1
2000
273
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2409
0.040
 Why?
Xanthine
1
2018
7
0.040
 Why?
Combined Modality Therapy
2
2013
1128
0.040
 Why?
Electrooculography
1
1997
10
0.040
 Why?
Visual Field Tests
1
1997
13
0.040
 Why?
Color Vision Defects
1
1997
6
0.040
 Why?
Fundus Oculi
1
1997
40
0.040
 Why?
Purines
1
2018
159
0.040
 Why?
Cohort Studies
2
2019
4960
0.040
 Why?
Child
2
2015
18555
0.030
 Why?
Photic Stimulation
1
1997
203
0.030
 Why?
Odds Ratio
1
2019
969
0.030
 Why?
Vision Disorders
1
1997
130
0.030
 Why?
Microbiological Techniques
1
2015
29
0.030
 Why?
Colony Count, Microbial
1
2015
112
0.030
 Why?
Myopia, Degenerative
1
2015
3
0.030
 Why?
Endotamponade
1
2015
4
0.030
 Why?
Metabolome
1
2018
286
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
28
0.030
 Why?
Pregnancy
1
2007
5556
0.030
 Why?
Disease Progression
2
2015
2424
0.030
 Why?
Mass Spectrometry
1
2018
661
0.030
 Why?
Photography
1
2015
89
0.030
 Why?
Atrophy
1
2015
154
0.030
 Why?
Biometry
1
2014
63
0.030
 Why?
Conjunctiva
1
2014
51
0.030
 Why?
Risk Factors
2
2019
8714
0.030
 Why?
Glucose
1
2018
904
0.030
 Why?
Fatty Acids, Omega-3
1
2014
125
0.030
 Why?
Risk Assessment
2
2014
3004
0.030
 Why?
Retreatment
1
2012
70
0.030
 Why?
Kaplan-Meier Estimate
1
2014
819
0.030
 Why?
Oxidative Stress
1
2018
1096
0.030
 Why?
Global Health
1
2014
292
0.020
 Why?
Proportional Hazards Models
1
2014
1088
0.020
 Why?
Survival Analysis
1
2014
1221
0.020
 Why?
Phenotype
1
2019
2861
0.020
 Why?
Health Care Costs
1
2014
386
0.020
 Why?
Antioxidants
1
2014
533
0.020
 Why?
Anticoagulants
1
2014
545
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
374
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
58
0.020
 Why?
Comorbidity
1
2014
1476
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
47
0.020
 Why?
Colorado
1
2019
4122
0.020
 Why?
Prospective Studies
2
2012
6267
0.020
 Why?
Retinal Artery
1
2007
15
0.020
 Why?
Cerebral Angiography
1
2007
111
0.020
 Why?
Infant
1
2000
8002
0.020
 Why?
Prognosis
1
2014
3342
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
26
0.020
 Why?
Frameshift Mutation
1
2006
27
0.020
 Why?
Anti-Bacterial Agents
1
2015
1486
0.020
 Why?
Secondary Prevention
1
2007
223
0.020
 Why?
Adrenal Cortex Hormones
1
2008
510
0.010
 Why?
Double-Blind Method
1
2007
1665
0.010
 Why?
RNA, Messenger
1
2007
2581
0.010
 Why?
Aging
1
2008
1640
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)